The full content of Annals is available to subscribers

Subscribe/Learn More  >
Consensus |

Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement

Consensus Development Conference Panel.
[+] Article, Author, and Disclosure Information

For panel and planning committee members, see Appendix.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1994;121(1):62-70. doi:10.7326/0003-4819-121-1-199407010-00013
Text Size: A A A

The National Institutes of Health Consensus Development Conference on Morbidity and Mortality of Dialysis brought together experts in general medicine, nephrology, pediatrics, biostatistics, and nutrition, as well as a representative of the public, to address the following questions: 1) How does early medical intervention in predialysis patients influence morbidity/mortality? 2) What is the relationship between delivered dialysis dose and morbidity/mortality? 3) Can comorbid conditions be altered by nondialytic interventions to improve morbidity/mortality in dialysis patients? 4) How can dialysis-related complications be reduced? and 5) What are the future directions for research in dialysis? After one and a half days of presentations by experts and discussion by the audience, a consensus panel weighed the evidence and prepared their consensus statement.

Among their findings, the consensus panel concluded the following: 1) During the period before dialysis therapy begins, patients, including children, should be referred to a renal team to reduce the morbidity and mortality incurred during this period and during subsequent dialysis therapy; 2) the social and psychological welfare and the quality of life of the patient receiving dialysis are favorably influenced by the early and continued involvement of a multidisciplinary renal team; 3) to avoid a catastrophic onset of dialysis, attempts should be made to institute intervention before dialysis therapy begins and to appropriately initiate dialysis access; 4) quantitative methods now available to objectively evaluate the relation between the delivered dose of dialysis and patient morbidity and mortality suggest that the dose of hemodialysis and peritoneal dialysis has been suboptimal for many patients in the United States; 5) factors contributing to the underdialysis of some patients include problems with vascular and peritoneal access, nonadherence to dialysis prescription, and underprescription of the dialysis dose; 6) cardiovascular mortality accounts for approximately 50% of deaths in patients receiving dialysis, and relative risk factors such as hypertension, smoking, and chronic anemia should be treated as soon as possible after the diagnosis of chronic renal failure; 7) early detection and treatment of malnutrition contribute to the improved survival of patients receiving dialysis; and 8) until randomized, controlled trials have been completed, a delivered hemodialysis dose at least equal to a measured fractional urea clearance Kdr t/V value of 1.2 (single pool) and a delivered peritoneal dialysis dose at least equal to a measured Kpr t/V value of 1.7 (weekly) are recommended.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.